MedPath

A study on The Effect of performing self-efficacy increasing program on type 2 diabetic patients HbA1c control

Not Applicable
Recruiting
Conditions
diabetes.
Registration Number
IRCT20180910040987N1
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
132
Inclusion Criteria

People who are willing to participate in the study
Have a diagnosis of type 2 diabetes
One year has passed since their diagnosis of diabetes
They have literacy and reading skills, and have high-level education
They are over 30 years old
Does not use insulin

Exclusion Criteria

Those with severe physical, cognitive and visual impairment that interfere with the ability to participate in the study (e.g., end-stage renal disease, hemodialysis, acute myocardial infarction, acute cerebrovascular accidents, or events that cause cognitive impairment)
People with gestational diabetes and type 1 diabetes will not be included in the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Self-efficacy. Timepoint: Before the intervention, after the end of the meeting (one month) and three months after the end of the meeting. Method of measurement: Self-efficacy questionnaire for patients with type 2 diabetes.
Secondary Outcome Measures
NameTimeMethod
HbA1c. Timepoint: Before the intervention and four months later. Method of measurement: spectrography.
© Copyright 2025. All Rights Reserved by MedPath